Ascelia Pharma AB

ACTIVE

Hyllie Stationstorg 31, Malmö, Skåne, Swedenwww.cmc-contrast.sePublic13 employeesEstablished: 1999-01-01

Clinical Trials

5 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

1999

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

87.5%

Phase 3

12.5%

Trial Status Distribution

Active, not recruiting

62.5%

Completed

12.5%

Recruiting

25.0%

Clinical Trials

Trials sponsored by this organization (8)

A Study of Mangoral in healthy humans

Phase 1

Recruiting

interventional

ASC-201 Plus Trifluridine/Tipiracil for the Treatment of Advanced Gastric Cancer

Phase 1

Active, not recruiting

Feb 2022139 participants

A Study of Mangoral in healthy humans

Phase 1

Recruiting

interventional

Aug 202148 participants

Safety and diagnostic Efficacy of Mangoral in Patients with abnormal liver cells and reduced kidney functio

Phase 1

Active, not recruiting

Jun 2021197 participants

Safety and Diagnostic Efficacy of Mangoral in Participants With Focal Liver Lesions and Reduced Kidney Function

Phase 3

Completed

interventional

Feb 202087 participants

A Multicenter, Open-label Study to Evaluate the Safety and Diagnostic Efficacy of Mangoral in Patients with Known or Suspected Focal Liver Lesions and Severe Renal Impairment

Phase 1

Active, not recruiting

Oct 2019200 participants

A Multicenter, Open-label Study to Evaluate the Safety and Diagnostic Efficacy of Mangoral in Patients with Known or Suspected Focal Liver Lesions and Severe Renal Impairment

Phase 1

Active, not recruiting

Sep 2019197 participants

A Multicenter, Open-label Study to Evaluate the Safety and Diagnostic Efficacy of Mangoral in Patients with Known or Suspected Focal Liver Lesions and Severe Renal Impairment

Phase 1

Active, not recruiting

Jul 2019197 participants

Approvals

No approval data available

News

No news articles found

Back to Organizations